News on DOV Pharmaceutical%2C Inc from BioPortfolio.com http://www.BioPortfolio.com Consolidated DOV Pharmaceutical%2C Inc news from BioPortfolio.com Wed, 10 Feb 2010 14:33:12 GMT en CNN - Why Doing Good Is Good For Businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998562&HITNO=0&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998562&THISHREF=http://c.moreover.com/click/here.pl%3fz2517119027%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998562&HITNO=0&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998562&THISHREF=http://c.moreover.com/click/here.pl%3fz2517119027%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsNet 5: CNN - Why Doing Good Is Good For Businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998536&HITNO=1&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998536&THISHREF=http://c.moreover.com/click/here.pl%3fz2517105828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998536&HITNO=1&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998536&THISHREF=http://c.moreover.com/click/here.pl%3fz2517105828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBayInsider: CNN - Why Doing Good Is Good For Businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998522&HITNO=2&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998522&THISHREF=http://c.moreover.com/click/here.pl%3fz2517103694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998522&HITNO=2&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998522&THISHREF=http://c.moreover.com/click/here.pl%3fz2517103694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWPXI: Why doing good is good for businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000356&HITNO=3&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000356&THISHREF=http://c.moreover.com/click/here.pl%3fz2517989203%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000356&HITNO=3&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000356&THISHREF=http://c.moreover.com/click/here.pl%3fz2517989203%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFortune: Why doing good is good for businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998381&HITNO=4&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998381&THISHREF=http://c.moreover.com/click/here.pl%3fz2517060246%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998381&HITNO=4&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998381&THISHREF=http://c.moreover.com/click/here.pl%3fz2517060246%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCNN: Why doing good is good for businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998532&HITNO=5&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998532&THISHREF=http://c.moreover.com/click/here.pl%3fz2517104939%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998532&HITNO=5&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998532&THISHREF=http://c.moreover.com/click/here.pl%3fz2517104939%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCNN Money: Dov Pharmaceutical Inc-Detailed Product Pipeline - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993647&HITNO=6&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993647&THISHREF=http://c.moreover.com/click/here.pl%3fz2514700346%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993647&HITNO=6&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993647&THISHREF=http://c.moreover.com/click/here.pl%3fz2514700346%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Saccharide foamable compositionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3973662&HITNO=7&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3973662&THISHREF=http://c.moreover.com/click/here.pl%3fz2503094029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3973662&HITNO=7&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3973662&THISHREF=http://c.moreover.com/click/here.pl%3fz2503094029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmCast: Form 4 Pharma-Bio Serv, Inc. For: Jan 04 Filed by: Perlysky Dovhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972245&HITNO=8&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972245&THISHREF=http://c.moreover.com/click/here.pl%3fz2502291495%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972245&HITNO=8&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972245&THISHREF=http://c.moreover.com/click/here.pl%3fz2502291495%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Leading Medication Development Researcher Phil Skolnick Joins NIDA to Lead Drug Discovery Effortshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940010&HITNO=9&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940010&THISHREF=http://c.moreover.com/click/here.pl%3fz2484876619%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940010&HITNO=9&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940010&THISHREF=http://c.moreover.com/click/here.pl%3fz2484876619%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAAPS Pharmceutica: Leading Medication Development Researcher Phil Skolnick Joins NIDA to Lead Drug Discovery Effortshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931238&HITNO=10&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931238&THISHREF=http://c.moreover.com/click/here.pl%3fz2480408558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931238&HITNO=10&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931238&THISHREF=http://c.moreover.com/click/here.pl%3fz2480408558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational Institutes of Health: The Potent Antioxidant Vitamin E May Do More Harm Than Good, TAU Research Suggestshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3850997&HITNO=11&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3850997&THISHREF=http://c.moreover.com/click/here.pl%3fz2440105642%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3850997&HITNO=11&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3850997&THISHREF=http://c.moreover.com/click/here.pl%3fz2440105642%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Newly Formed Durata Therapeutics Acquires Pfizer's Vicuron Subsidiaryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3812295&HITNO=12&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3812295&THISHREF=http://c.moreover.com/click/here.pl%3fz2416089861%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3812295&HITNO=12&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DOV%20Pharmaceutical,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3812295&THISHREF=http://c.moreover.com/click/here.pl%3fz2416089861%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: